Navigation Links
CSL Therapy That Mimics 'Good' Cholesterol May Reduce Plaque Volume,in Coronary Arteries

examination of the blood vessels.

183 patients received placebo (n=60), 40 mg/kg (n=111) or 80 mg/kg (n=12) of CSL-111. The higher dosage of CSL-111 was discontinued early because of transient liver function test abnormalities. The 40mg/kg dose was safe and generally well tolerated.

The results were based on data from 145 patients who had two sequential IVUS procedures. The main findings were that there was a reduction in coronary plaque volume after infusions of CSL-111 of 3.4 percent and after placebo of 1.6 percent, which were not statistically significantly different. However, when compared to baseline, the reduction for patients infused with CSL-111 was statistically significant (p< 0.001), but this was not the case in the placebo group. Other assessments of the plaque, such as characterization indexes or changes in plaque that are different than volume measurements, on IVUS and coronary score on QCA, were significantly different between CSL-111 and placebo. Interestingly, the difference in coronary score between patients that had 4 weeks of CSL-111 and those given placebo was similar to those observed after two years of statin treatment (compared with no statin).

"Overall, these results strongly suggest that CSL-111 is biologically active, and that short term infusions of CSL-111 result in a rapid, favourable effect on coronary atherosclerotic plaque," said Jean-Claude Tardif, M.D., of the Montreal Heart Institute, University of Montreal, and lead author of the study. "These data strongly support the conduct of further clinical studies to assess whether CSL-111 will provide a clinical benefit to patients with ACS."

"This study is a significant step in our development of CSL-111," said Dr. Andrew Cuthbertson, Chief Scientific Officer, CSL Ltd. "CSL recognizes the value that CSL-111 may provide in preventing further cardiovascular events in patients with ACS. We are committed to exploring the full therapeutic potential of this treatme
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
2. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
3. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
4. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
5. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
6. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
7. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
8. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
9. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
10. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
11. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
Post Your Comments:
(Date:9/29/2014)... -- Bob Pack, who lost his two young children to ... Association to immediately cease airing a television ad from ... News called "shamelessly deceptive" and of which the LA ... about the measure is wrong." The ... doctors check California,s existing statewide ...
(Date:9/29/2014)... 2014 Dynatronics Corporation (NASDAQ: ... investors today at 2:00 p.m. ET to discuss ... June 30, 2014.  The corrected call-in number for ... Dynatronics manufactures, markets and distributes advanced-technology medical ... and rehabilitation equipment for the physical therapy, sports ...
(Date:9/29/2014)... BOGOTA, Colombia , Sept. 29, 2014 /PRNewswire/ ... has announced a promising new drug treatment: ... 3-bromopyruvate (3-BrPA) that has already proven successful at ... medical researchers behind this novel treatment are optimistic ... patients who have exhausted current therapeutic avenues. ...
Breaking Medicine Technology:Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 2Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 3Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 4Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 5Cancer Treatment Institute of Colombia Demonstrates Unprecedented Results Using Unique Cancer Drug Combination of 3-Bromopyruvate and Salinomycin for Treatment of Multiple Types of Cancer 2Cancer Treatment Institute of Colombia Demonstrates Unprecedented Results Using Unique Cancer Drug Combination of 3-Bromopyruvate and Salinomycin for Treatment of Multiple Types of Cancer 3
... Reportlinker.com announces that a new ... its catalogue: External ... Russia, India, China, South Africa) to ... External Defibrillator Market ...
... Orthopedic Group, Inc. today announced the appointment of Vinit ... immediately.  Mr. Asar joined the company in December 2008 ... nearly 20 years of global business operations experience in ... his new position, Mr. Asar will continue to lead ...
Cached Medicine Technology:External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 2External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 3External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 4External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 5External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 6External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 7External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 8External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 9External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 10External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 11External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 12External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 13External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 14External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 15External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 16External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 17External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 18External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 19Hanger Orthopedic Group Appoints Vinit K. Asar to President and Chief Operating Officer 2Hanger Orthopedic Group Appoints Vinit K. Asar to President and Chief Operating Officer 3
(Date:9/30/2014)... 2014 In honor of National Breast ... and their courageous battles, Incredible Veins, Body & Skin ... PicoSure® by Cynosure. , “For cancer patients who ... is applied on their skin to accurately aim the ... “For many survivors, they decide to have their tattoo ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 In ... well as better data capture and management functions ... ClinCapture electronic data capture (EDC) system. ClinCapture offers ... ability to easily manage clinical trial data and ... cement Synergy’s position as the leading clinical research ...
(Date:9/30/2014)... high-dose vitamin D3 compared with placebo did not reduce ... of stay, hospital mortality, or the risk of death ... who were critically ill, according to a study published ... early online to coincide with its presentation at the ... , A high prevalence of low vitamin D levels ...
(Date:9/30/2014)... Delhi, India (PRWEB) September 30, 2014 RBS ... reputation management service named ‘Remove Your Name’. , The ... being asked reason behind giving the service this odd name, ... there is nothing odd in this name. We have named ... as well as organizations to get rid of all those ...
(Date:9/30/2014)... Massachusetts (PRWEB) September 30, 2014 ... Wingate of East Longmeadow facility has officially announced ... Ventilator Program that combines advanced medical technology ... program is one of the only non-hospital options ... of care. The primary focus of this ...
Breaking Medicine News(10 mins):Health News:Incredible Veins, Body & Skin Takes A Stand Against Breast Cancer With PicoSure® By Cynosure 2Health News:Synergy Research Group Opts for Clinovo 2Health News:Synergy Research Group Opts for Clinovo 3Health News:High-dose vitamin D for ICU patients who are vitamin D deficient does not improve outcomes 2Health News:RBS Reputation Management Announces A New Service ‘Remove Your Name’ 2Health News:Wingate Healthcare Announces New Ventilator Care Program at East Longmeadow Facility 2Health News:Wingate Healthcare Announces New Ventilator Care Program at East Longmeadow Facility 3
... activities and may make men smarter by enabling them ... study.// ,Researchers studied the effects of fatherhood ... that spend 70 percent of their time caring for ... time, according to new research by Princeton University psychologist ...
... people are hit harder by hangover while teenagers have a ... ,US psychologist Elena Varlinskaya and other researchers studied the effects ... teenagers and adults. , ,The rats - chosen because ... with alcohol and their movements monitored, reported the online edition ...
... personnel returning from vacation, the Central Reserve Police Force (CRPF) ... ,"We have found that over 80 percent of ... personnel who had returned from leave," said a CRPF official ... official added that the trend was mostly sighted in Delhi, ...
... pain and disc disorder now have a reason to ... results than conventional// surgery. ,Ozonucleolysis, as the ... western countries, according to senior doctors who are here ... ozone discectomy for curing spinal injury is a better ...
... in Chennai attracted a visitor from the Safari country ... osteoarthritis of both knees underwent bilateral// knee replacements here ... Orthopedic surgeon remarked that this was the first time ... for bilateral knee replacements. His son, a UK based ...
... research findings show men have fewer long-term gastrointestinal ... with three-dimensional// conformal radiation therapy (3D CRT) for ... radiation used in the IMRT group. These and ... presented today at the 48th Annual Meeting of ...
Cached Medicine News:Health News:Older People Get Worse Hangovers 2Health News:CRPF To Issue Contraceptives To Fight AIDS 2Health News:Ozone Treatment - A Good Alternative For Spinal Injury 2Health News:IMRT Versus 3D CRT For Prostate Cancer, New Long-Term Data Assesses Side Effects 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: